Literature DB >> 22901113

Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy.

Spoorthy N Babu1, Gaurav Chetal, Sudhir Kumar.   

Abstract

Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine which plays roles in inflammation, immune responses and cancer development. It assists macrophages in carrying out functions like phagocytosis, adherence and motility. Of late, MIF is implicated in almost all stages of neoplasia and expression is a feature of most types of cancer. The presence of MIF in almost all tumors and all stages of cancer makes it an interesting candidate for cancer therapy. This review explores the roles of MIF in neoplasia.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22901113     DOI： 10.7314/apjcp.2012.13.5.1737

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN： 1513-7368


  22 in total

1.  Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.

Authors:  Junko Haraga; Keiichiro Nakamura; Chiaki Omichi; Takeshi Nishida; Tomoko Haruma; Tomoyuki Kusumoto; Noriko Seki; Hisashi Masuyama; Norihisa Katayama; Susumu Kanazawa; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2016-09-21

2.  Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; Michael J Robertson; José A Cisneros; Stefan G Krimmer; William L Jorgensen
Journal:  ChemMedChem       Date:  2018-04-23       Impact factor: 3.466

Review 3.  Environmental immune disruptors, inflammation and cancer risk.

Authors:  Patricia A Thompson; Mahin Khatami; Carolyn J Baglole; Jun Sun; Shelley A Harris; Eun-Yi Moon; Fahd Al-Mulla; Rabeah Al-Temaimi; Dustin G Brown; Annamaria Colacci; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Roslida A Hamid; Leroy Lowe; Tiziana Guarnieri; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

4.  Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling.

Authors:  Kathryn A Bailey; Jessica Laine; Julia E Rager; Elizabeth Sebastian; Andrew Olshan; Lisa Smeester; Zuzana Drobná; Miroslav Styblo; Marisela Rubio-Andrade; Gonzalo García-Vargas; Rebecca C Fry
Journal:  Toxicol Sci       Date:  2014-03-27       Impact factor: 4.849

Review 5.  Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer.

Authors:  Camila Cristina Guimarães Nobre; Josélio Maria Galvão de Araújo; Thales Allyrio Araújo de Medeiros Fernandes; Ricardo Ney Oliveira Cobucci; Daniel Carlos Ferreira Lanza; Vânia Sousa Andrade; José Veríssimo Fernandes
Journal:  Pathol Oncol Res       Date:  2016-10-23       Impact factor: 3.201

6.  Diabetes-associated dysregulated cytokines and cancer.

Authors:  Yong Wu; Yanjun Liu; Yunzhou Dong; Jay Vadgama
Journal:  Integr Cancer Sci Ther       Date:  2016-02-15

7.  P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor.

Authors:  Xiu-Jun Li; Yi Luo; Yong-Fen Yi
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 8.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

9.  Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients.

Authors:  Faruk Tas; Senem Karabulut; Murat Serilmez; Rumeysa Ciftci; Derya Duranyildiz
Journal:  Tumour Biol       Date:  2013-11-24

Review 10.  The role of MIF in type 1 and type 2 diabetes mellitus.

Authors:  Yuriko I Sánchez-Zamora; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2014-01-02       Impact factor: 4.011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.